Sera from adult patients with cystic fibrosis contain antibodies to Pseudomonas aeruginosa type III apparatus.
about
Rhamnolipids are virulence factors that promote early infiltration of primary human airway epithelia by Pseudomonas aeruginosaThe Pseudomonas aeruginosa PA01 gene collectionExsE, a secreted regulator of type III secretion genes in Pseudomonas aeruginosa.Pathogen proteins eliciting antibodies do not share epitopes with host proteins: a bioinformatics approach.Modulation of bacterial Type III secretion system by a spermidine transporter dependent signaling pathway.Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infectionEarly immune response to the components of the type III system of Pseudomonas aeruginosa in children with cystic fibrosisClinical significance of microbial infection and adaptation in cystic fibrosis.Cis-2-dodecenoic acid signal modulates virulence of Pseudomonas aeruginosa through interference with quorum sensing systems and T3SSPseudomonas aeruginosa Bacteremic Patients Exhibit Nonprotective Antibody Titers Against Therapeutic Antibody Targets PcrV and Psl Exopolysaccharide.Metabolic regulation of type III secretion gene expression in Pseudomonas aeruginosa.Pseudomonas aeruginosa virulence and therapy: evolving translational strategies.The type III secretion system of Pseudomonas aeruginosa: infection by injection.Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis.Examination of the coordinate effects of Pseudomonas aeruginosa ExoS on Rac1.Epidemiological analysis of serum anti-Pseudomonas aeruginosa PcrV titers in adults.A Novel Insight into Dehydroleucodine Mediated Attenuation of Pseudomonas aeruginosa Virulence Mechanism.The deletion of TonB-dependent receptor genes is part of the genome reduction process that occurs during adaptation of Pseudomonas aeruginosa to the cystic fibrosis lung.Auto-ADP-ribosylation of Pseudomonas aeruginosa ExoS.In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors.Mouse Immunization with Purified Needle Proteins from Type III Secretion Systems and the Characterization of the Immune Response to These Proteins.in Chronic Lung Infections: How to Adapt Within the Host?
P2860
Q24548276-9EE08CF2-2F93-4CE1-B350-1956B0FF4D25Q28288305-0072CEFA-68AC-4122-9C09-D698E937B32AQ28492983-68059ECF-EEDA-4E8B-AC46-6DEDB0FC8E19Q33286824-B0F24C00-A08C-4714-B97A-42626DE505FBQ33309938-5A499145-BD24-473E-A07D-3B04312DEECCQ33716022-7D14DC46-769B-4BC9-9424-F74A01C43DCBQ34041909-09D3198E-9995-476E-A1D3-2BDD2088B404Q34491552-09BE397E-C2C6-4EE6-A681-4BC0B413CFA3Q35019815-FD6DCEE0-53A4-4CF4-9ADC-F9E2F2189D03Q36487854-2F6E7480-A6E1-461C-B4F1-6DB15A337BFEQ37124570-58D06148-6AA6-4E47-9B53-5D75C585431BQ37358382-96E61A9D-8A30-4C05-8CA9-2D21910C94A9Q37397923-5ED8A716-583B-44CA-95C0-8CDF0943561CQ37597434-334E2511-58D6-4004-B6E4-27BA942680E9Q40382973-A4BC7068-C6A2-4452-87A3-623BC623BC9CQ40860257-2E21B188-8D4A-4ABC-B3B9-57F6AF20A6D6Q40881386-0C7B641B-815E-4B03-9AB3-464A2974A922Q42650446-A0240C53-6120-4842-9F2E-6C8239BBD72FQ43872729-2671AECD-A2D7-4218-8A0C-8A0C51BB8464Q44547313-B3E61697-61B0-4660-8149-1FED597014AAQ51330870-6E392BA3-66E2-4F96-A4CC-2F1F04E82115Q58580408-234FA829-B436-4DCF-BEB8-9DA8EBC331DE
P2860
Sera from adult patients with cystic fibrosis contain antibodies to Pseudomonas aeruginosa type III apparatus.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Sera from adult patients with ...... aeruginosa type III apparatus.
@ast
Sera from adult patients with ...... aeruginosa type III apparatus.
@en
Sera from adult patients with ...... aeruginosa type III apparatus.
@nl
type
label
Sera from adult patients with ...... aeruginosa type III apparatus.
@ast
Sera from adult patients with ...... aeruginosa type III apparatus.
@en
Sera from adult patients with ...... aeruginosa type III apparatus.
@nl
prefLabel
Sera from adult patients with ...... aeruginosa type III apparatus.
@ast
Sera from adult patients with ...... aeruginosa type III apparatus.
@en
Sera from adult patients with ...... aeruginosa type III apparatus.
@nl
P2093
P2860
P1476
Sera from adult patients with ...... aeruginosa type III apparatus.
@en
P2093
B D Banwart
J T Barbieri
M E Ehrmantraut
P2860
P304
P356
10.1128/IAI.69.2.1185-1188.2001
P407
P577
2001-02-01T00:00:00Z